Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial.

Cohen, Stanley; Samad, Ahmed; Karis, Elaine; Stolshek, Bradley S; Trivedi, Mona; Zhang, Hao; Aras, Girish A; Kricorian, Greg; Chung, James B

Cohen, Stanley; Samad, Ahmed; Karis, Elaine; Stolshek, Bradley S; Trivedi, Mona; Zhang, Hao; Aras, Girish A; Kricorian, Greg; Chung, James B.

Afiliación

Cohen S; Metroplex Clinical Research Center, Dallas, TX, USA. scohen@arthdocs.com.
Samad A; US Medical, Amgen Inc., Thousand Oaks, CA, USA.
Karis E; US Medical, Amgen Inc., Thousand Oaks, CA, USA.
Stolshek BS; US Medical, Amgen Inc., Thousand Oaks, CA, USA.
Trivedi M; US Medical, Amgen Inc., Thousand Oaks, CA, USA.
Zhang H; Biostatistics, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA.
Aras GA; Biostatistics, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA.
Kricorian G; US Medical, Amgen Inc., Thousand Oaks, CA, USA.
Chung JB; US Medical, Amgen Inc., Thousand Oaks, CA, USA.

Rheumatol Ther ; 6(2): 245-254, 2019 Jun.

Article en En | MEDLINE | ID: mdl-30915626

Palabras clave

Etanercept; Injection site pain; Phosphate-free formulation; Psoriatic arthritis; Rheumatoid arthritis; Subcutaneous injection

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Rheumatol Ther Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google